By proceeding, you agree to our Terms of Use and Privacy Policy.
Group Director, Real-World Value & Evidence - Hematology - TECVAYLI Lead
#pharmacoeconomics #epidemiology #healthcare #medicine
#NorthAmerica
I'm an inspirational and well-respected leader in generating scientific evidence and business impactful insights via health economics and outcomes research, data visualization, and predictive analytic
Research Fellow
#pharmacoeconomics #pharmacoepidemiology
Dr. C Andrew Basham PhD, is a Research Fellow in the Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, where he conducts research on prescription opioid utilization
Chief Community Officer
#formularymanagement #pharmacoeconomics
Chandler Schexnayder is a dedicated servant-leader, wholly committed to elevating patient care, nurturing the growth of pharmacy trainees, uniting colleagues, and empowering communities.An acc
Director, Pharmacoepidemiology
#pharmacoepidemiology #pharmacoeconomics #healthcare
Christian Hampp is a distinguished Director of Pharmacoepidemiology known for his exceptional contributions to the field. With a wealth of experience, he has demonstrated a remarkable aptitude for des
Vice President
#pharmacoepidemiology #pharmacoeconomics
#Europe
Marianne Cunnington is currently a Vice President in the Healthcare Practice at Analysis Group and has 20 years of experience working as an industry pharmacoepidemiologist leading real world benefit r
Director, Precision Medicine Policy
#medicine #policy #regulatoryaffairs #pharmacoeconomics
29 years (last 11 years within precision medicine) of pharmaceutical industry experience communicating mostly to UK and EU payers and prescribing policy decision makers, MPs and patient advocates, hea